Content by Keyword: Patient Safety

  • Home
  • Patient Safety
  • print
  • email
  • twitter
  • compact
Report page
Appendix E – Key Informants

Understanding the High Prevalence of Low-Prevalence Chronic Disease Combinations: Databases and Methods for Research. Appendix E – Key Informants

Below is the list of key informants and their affiliations. Key informants were identified by the ASPE Project Officers and the Technical Advisory Group (TAG). Key informant interviews were conducted by telephone to provide the Project Team with in-depth expertise on topics covered in the White Paper. Findings from the Key Informant Interviews hav
Report page
Appendix D – Technical Advisory Group Members

Understanding the High Prevalence of Low-Prevalence Chronic Disease Combinations: Databases and Methods for Research. Appendix D – Technical Advisory Group Members

The Technical Advisory Group (TAG) included experts from several federal HHS agencies who consulted about the content and design of the study. TAG members participated in an initial in-person meeting in December 2012 and provided feedback on the original literature review to determine additional databases, grouping systems, and methods for studyin
Report page
Defining Diagnosis of Chronic Condition

Understanding the High Prevalence of Low-Prevalence Chronic Disease Combinations: Databases and Methods for Research. Defining Diagnosis of Chronic Condition

There are two main sources of information about patients’ chronic conditions: 1) surveys that collect self-reported disease status, and 2) claims and clinical systems that contain diagnosis codes (e.g., International Classification of Disease, 9 th edition [ICD-9], ICD-10, Systematized Nomenclature of Medicine Clinical Terms [SNOMED CT]). Other
Report page
Stakeholder Perspectives

Understanding the High Prevalence of Low-Prevalence Chronic Disease Combinations: Databases and Methods for Research. Stakeholder Perspectives

It is important to note that the significance of examining less prevalent, or rare, MCC combinations depends on the perspective of the stakeholder, which ranges from the patient to the provider to the health plan risk adjuster. A clinician trying to assess the best course of treatment for a patient has different information needs than does a healt
Report page
V. Summary of Service Category Findings

Medicare's Bending Cost Curve. July 28, 2014. V. Summary of Service Category Findings

While these finding are not definitive, they offer suggestive information about the factors that may have affected recent Medicare spending trends. As noted below, in many cases, multiple factors may have contributed to trends for individual service categories.
Report page
4.5.4 Conservative Regulatory Climate

Examination of Clinical Trial Costs and Barriers for Drug Development. 4.5.4 Conservative Regulatory Climate

Nearly all of the company representatives and experts interviewed commented on what they perceived as a particularly risk-averse regulatory climate of recent years. Many framed the problem as a disproportionate weighting of risk in the risk-benefit equation, with FDA now appearing hesitant to take on even small amounts of risk, regardless of the
Report page
4.5.2 Safety Reporting Requirements for

Examination of Clinical Trial Costs and Barriers for Drug Development. 4.5.2 Safety Reporting Requirements for Investigational New Drugs (INDs) and Biologics (21 CFR 312)

In the course of clinical investigations conducted under investigational new drug (IND) applications, information regarding adverse events must be communicated among investigators, sponsors, IRBs, and FDA in safety reports. There are a number of terms that are used to categorize adverse events and thereby determine which must be reported. The most
Report page
V. ORGANIZATIONAL CHANGE—RAPID CYCLE EVALUATION

Rapid Evaluation Approaches for Complex Initiatives. V. Organizational Change—rapid Cycle Evaluation

This section provides an example of an organizational change evaluation used in the implementation of the Partnerships for Patients Program (PfP). Table 3 features the unique factors of organizational change evaluations. In Table 3, the ten evaluation factors are listed (in the left-hand column), the factors are applied to organizational change pr
Report page
Session 3: What Are the Re-identification Threats

Minimizing Disclosure Risk in HHS Open Data Initiatives. Session 3: What Are the Re-identification Threats to Releasing Federal Data to the Public?

Steve Cohen, AHRQ (moderator) Daniel Barth-Jones, Columbia University Khaled El Emam, University of Ottawa and Privacy Analytics Denise Love, National Association of Health Data Organizations (NAHDO) Brad Malin, Vanderbilt University Latanya Sweeney, Federal Trade Commission and Harvard University Cohen: We need to be forward looking—let’s t
Report
Minimizing Disclosure Risk in HHS Open Data

Minimizing Disclosure Risk in HHS Open Data Initiatives

Federal agencies have a long history of releasing data to the public, and they also have a legal obligation to protect the confidentiality of the individuals and organizations from which the data were collected. Federal agencies have successfully balanced these two objectives for decades. With the new emphasis on expanding public access to federal
  • rpt_Disclosure.pdf
    export-csvPDF
Report page
What Infrastructure, Tools and Data Are Needed to

Performance Improvement 2013-2014. What Infrastructure, Tools and Data Are Needed to Measure Ambulatory Care Patient Safety Events?

Since the Institute of Medicine published its landmark study “To Err is Human” in 2000 estimating that up to 98,000 deaths in hospitals result from medical errors, much attention has been paid to medical errors in the hospital setting. Despite a shift towards increasing delivery of care in the outpatient setting, comparatively little is known
Report page
Objective: Improve health care quality and

Performance Improvement 2013-2014. Objective: Improve health care quality and patient safety

Report page
Objective: Improve health care quality and

Performance Improvement 2011-2012. Objective: Improve health care quality and patient safety

Report
Performance Improvement 2011-2012

Performance Improvement 2011-2012

This report, Performance Improvement 2011-2012, the 17th in this series, summarizes the key findings from studies completed during the two fiscal-year period ending September 30, 2011.
  • PerformanceImprovement2011-2012.pdf
    export-csvPDF
Report page
Does Essential Health Information Get Exchanged

Performance Improvement 2009. Does Essential Health Information Get Exchanged in Post-Acute and Long-Term Care Settings; By What Means; What Encourages or Prevents Such Exchange?

This study sought answers to three questions: what type of health information needs to be exchanged on behalf of patients receiving post-acute and long-term care services as they move from one care setting to another and when does information need to be exchanged among their physicians, pharmacies, and other providers; how is health information e
Report page
Could Good Clinical Practice Computer-Based

Performance Improvement 2008. Could Good Clinical Practice Computer-Based Training Change Researcher Behaviors and Improve Human Subject Safety, Data Integrity and Research Efficiency?

A feasibility study of the Good Clinical Practice (GCP) Computer-Based Training program was conducted to determine whether an outcome evaluation could be designed to provide objective data on whether the training program improved outcomes such as quality of data and patient safety. The GCP training program was implemented to provide a single train
Report page
9. Preparations for Health Reform by Safety Net

Environmental Scan to Identify the Major Research Questions and Metrics for Monitoring the Effects of the Affordable Care Act on Safety Net Hospitals. 9. Preparations for Health Reform by Safety Net Hospitals

How successfully safety net hospitals can adapt to the reforms will depend on the financial performance of the hospitals before reform, as well as the preparations they have made in anticipation of reform. In particular, the TEP identified the scope of future pension obligations of safety net hospitals that offer defined benefit plans—especially
Report page
How Can Barriers to Interoperable Health

Performance Improvement 2007. How Can Barriers to Interoperable Health Information Technology in Post-Acute and Long-Term Care Be Reduced; Can Patient Data Be Made to Comply with Health Information Technology Standards?

Summary:
Report page
What Features and Capabilities of Electronic

Performance Improvement 2007. What Features and Capabilities of Electronic Medical Records Best Serve Doctors in Small Practices?

Summary:
Report page
What Role Does the Physician Discipline Function

Performance Improvement 2007. What Role Does the Physician Discipline Function of State Medical Boards Play in Assessing Medical Quality?

Summary:

Pages

Form Approved OMB# 0990-0379 Exp. Date 9/30/2020